These compounds produce anti-tumor activity by triggering apoptosis, controlling the cell cycle, and regulating multiple signaling pathways like the NF-kB pathway, the p53 pathway, and the inflammatory pathway. The gene discussed is NFKB1; the disease is neoplasm.